Abstract
Objective
To investigate the expressions and molecular mechanism of Ets-1 mRNA, and TGFβ1 and c-Met proteins in the pathogenesis, progression of lung cancer by tissue microarray (TMA) method.
Methods
The expressions of Ets-1 mRNA, and TGFβ1 and c-Met proteins were detected in 89 primary lung cancers, 12 lung cancer with lymph-node metastasis and 12 precancerous lesions by FISH(fluorescence in situ hybridization) and immunohistochemical method, and 10 normal lung tissues were used as controls.
Results
The expressions of Ets-1 mRNA, and TGFβ1 and c-Met proteins were significantly higher in 89 primary lung cancer than in the control group (P<0.05). The expressions of Ets-1 mRNA, and TGFβ1 and c-Met proteins were related to lymph node metastasis and clinical stages. There was a positive correlation between the Ets-1 mRNA expression and TGFβ1 and c-Met proteins (P<0.05).
Conclusion
Ets-1 mRNA, TGFβ1 and c-Met proteins may be related to the pathogenesis, progression and malignant behavior of lung cancer. They may play an important role in prognosis assessment of lung cancer.
Similar content being viewed by others
References
Parkin DM, Pisani P, Ferlay J. Global cancer statistics [J]. CA Cancer J Clin 1999;49:33–64.
Travis WD, Brambila E, Muller-Hermelink GK, et al. World Health Organization Classification of Tumors, Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heat [M]. Lyon: LARC Press. 2004; 9–124.
Tan Yu-bin, Zhang Nai-xin, ed. Surgical Diagnostic Pathology. Tianjin: Tianjin Science Technologic Publishing (in Chin). 2000; 568–577.
Li Yan, Wang Xin-yun, Liu Ting, et al. The significance of bGFG in lung cancer and precancerous lesions by tissue microarray [J]. Chin J Cancer Preven Treat (in Chin) 2004;12:668–671.
Xu JP, Bai XG. The test of TGFβ1 in the blood with hepatitis, liver cirrhosis and liver carcinoma [J]. Chin J Exp Clin Pathol (in Chin) 2002; 16:235.
Bolon I, Brambilla E, Vandenbunder B, et al. Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions [J]. Lab Invest 1996; 75:1–13.
Bolon I, Gouyer V, Devouassoux M, et al. Expression of c-Ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas [J]. Am J Pathol 1995;147:1298–1310.
Ito Y, Takeda T, Okada M, et al. Expression of Ets1 and Ets2 in colon neoplasoma [J]. Anticancer Res 2002; 22:1581–1584.
Wang XY, Yang JH, Ma Y, et al. The expression MMPs and TIMPs of and research of invasion and metastasis in lung cancer [J]. Chin J Lung Cancer (in Chin) 2003; 6:278–282.
Shin SJ, Kim KO, Kim MK, et al. Expression of E-cadherin and uPA and their association with the prognosis of pancreatic cancer [J]. Jpn J Clin Oncol 2005; 35:342–348.
Hashiya N, Jon, Aoki M, et al. In vivo evidence of angiogenesis induced by transcription factor Ets-1 [J]. Circulation 2004; 109:3035–3041.
Yao X, Liu XJ, Zhang L, et al. The significance of TGFβ1 and its receptor in human bladder transitional cell carcinoma [J]. Chin J Oncol (in Chin) 2002; 24:158.
Shim KS, Kim KH, Han WS, et al. Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection [J]. Cancer 1999;85:554–561.
Luo K, Stroschein SL, Wang W, et al. The Ski oncoprotein interacts with the Smad proteins to repress TGF-beta signaling [J]. Genes Dev 1999; 13:2196–2206.
Czuwara-Ladykowska J, Sementchenko VI, Watson DK, et al. Ets-1 is an effector of the transforming growth factor beta (TGF-beta) signaling pathway and an antagonist of the profibrotic effects of TGF-beta [J]. J Biol Chem 2002; 277:20399–20408.
Kopp JL, Wilder PJ, Desler M, et al. Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the promoter of the type II transforming growth factor-beta receptor gene [J]. J Biol Chem 2004; 279:19407–19420.
Yamaura T, Murakami K, Doki Y, et al. Solitary lung tumors and their spontaneous metastasis in athymic nude mice orthotopically implanted with human non-small cell lung cancer [J]. Neiplasia 2000; 2:315–324.
Saeki H, Oda S, Kawaguchi H, et al. Concurrent overexpression of Ets-1 and c-Met correlates with a phenotype of high cellular motility in human esophageal cancer [J]. Int J Cancer 2002; 98:8–13.
Tomita N, Morishita R, Taniyama Y, et al. Angiogenic property of hepatocytes growth factor is dependent on upregulation of essential transcription factor for angiogenesis ets-1 [J]. Circulation 2003; 107:1411–1417.
Jiang Y, Xu W, Lu J, et al. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocytes growth factor, c-Met, and transcription factor Ets-1 [J]. Biochem Biophys Res Commun 2001;286:1123–1130.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Song, Wj., Wang, Xy. & Sun, Cy. Biological significance and the related molecular mechanism of Ets1 mRNA expression in lung cancer by tissue microarray (TMA). Chin. J. Cancer Res. 19, 176–183 (2007). https://doi.org/10.1007/s11670-007-0176-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11670-007-0176-4